Sixteen months into this virus, our government has nothing to offer us in terms of treatment in the hospital but remdesivir at $3,100 a dose and zero treatment options at the critical early stage, when serious complications can be pre-empted. Now, a new study from the...
RPI 2019 Scholars lunching with US Rep. John Duncan, Jr. ***Apply HERE***We're back! The Ron Paul Institute is pleased to announce the second Ron Paul Scholars' Seminar. The first Seminar, held in 2019, was a great success and thanks to generous sponsors we are able...
It does not seem fair. This week, Johnson & Johnson was called out by the Food and Drug Administration (FDA) for problems with Johnson & Johnson’s experimental coronavirus vaccine. While experimental coronavirus vaccine competitors Moderna and Pfizer-BioNTech...
